Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Medigene AG
< Previous
1
2
Next >
Medigene presents UniTope and TraCR a universal detection system for 3S recombinant TCRs at ASGCT 2024
October 17, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at Upcoming Scientific Conferences
October 16, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene will Present at ASGCT 2024 and Host R&D Event
October 02, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Expands Protection of its KRAS Library with Filing of New Patent Application Supporting MDG2021
September 25, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Host Virtual R&D Event on Medigene’s Optimal 3S TCRs for TCR-Guided Precision Immunotherapies
September 16, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Progress on KRAS Library and UniTope & TraCR Technology at ESMO 2024
September 14, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Announces U.S. FDA Clearance of IND Application for MDG1015, a First-in-Class, Third Generation T Cell Receptor Engineered T Cell (TCR-T) Therapy for Multiple Solid Tumor Indications
September 05, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform
August 29, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at Upcoming Investor Conferences
August 28, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG implements announced 2:1 share capital reduction and consolidation of the shares effective August 29, 2024
August 26, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Reports Half-Year 2024 Financial Results and Provides Corporate Update
August 14, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG to Report Half-Year 2024 Financial Results on August 14, 2024
August 08, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers
August 08, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at ESMO Congress 2024
July 23, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Expands Patent Portfolio with the Patent Grant for its NY-ESO-1/LAGE 1a Targeted T Cell Receptor in China
July 03, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Efficient 6-Day TCR-T Therapy Production Process with High Stemness
June 27, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Reports Results of Annual General Meeting
June 24, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at the Cell and Gene Therapy In-Depth Focus Summit 2024
June 21, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Announces Lead Selection for MDG2021, Expanding TCR-T KRAS Library Targeting Solid Tumors
June 20, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Expands its End-to-End Platform by Submitting Three Development Optimization Technology Patents to the European Patent Office
May 28, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene's Global Research & Collaboration Agreement with BioNTech to Extend Beyond Initially Announced Term
May 21, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS
May 15, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Extends Cash Runway into July 2025 After Successful Oversubscribed Capital Raise
May 14, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at Upcoming Conferences
May 07, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor
May 02, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
May 02, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
April 25, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene to Present at Upcoming Scientific Conferences
April 17, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
April 08, 2024
From
Medigene AG
Via
GlobeNewswire
Medigene AG Secures European Patent for its iM-TCR Technology
April 04, 2024
From
Medigene AG
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.